Specifically, only 200 CD44+/CD24-/low/ESA+/lin- breast cancer cells, isolated from patient primary tumors, could regenerate and expand to form secondary tumors that also contained CSCs, in as little as 12 weeks in mice (Al-Hajj et al., 2003). Here, CD44 is linked to breast carcinoma.